Results 141 to 150 of about 51,158 (208)

Dosimetric and clinical outcomes study of occult uterine tandem imperfect implantation in HDR-brachytherapy for cervical cancer. [PDF]

Sci Rep
Zhao X, Wu H, Yi R, Chen D, Tang Y, Zhou Q, Zou D.   +6 more
europepmc   +1 more source

Implementation of needle-tracking technology for real-time transrectal ultrasound-guided interstitial gynecological HDR brachytherapy: A feasibility study. [PDF]

J Appl Clin Med Phys
Bloom LH, Ayala-Peacock D, Venkataraman R, Eckroate B, Sanford R, Chino J, Kim Y, Raffi J, Craciunescu O.   +8 more
europepmc   +1 more source

Dosimetric Comparison of VMAT Alone and VMAT with HDR Brachytherapy Boost Using Clinical and Biological Dose Models in Localized Prostate Cancer. [PDF]

Curr Oncol
Guhlich M, Knaus O, Strauss A, Fischer LA, Fischer J, Bendrich S, Donath S, Dröge LH, Leu M, Rieken S, Uhlig A, Schirmer MA, Hille A.   +12 more
europepmc   +1 more source

Commissioning of the Varian universal interstitial cylinder system for HDR brachytherapy of gynecological cancer. [PDF]

J Appl Clin Med Phys
Meltsner S, Craciunescu O, Raffi J, Lee C, Sheng Y, Chino J, Ayala-Peacock D, Kim Y.   +7 more
europepmc   +1 more source

Reevaluating BED in cervical cancer HDR brachytherapy: source decay and tissue-specific repair significantly impact radiobiological dose. [PDF]

Front Oncol
Bi S, Zhou J, Xu M, Dai Z.
europepmc   +1 more source

Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy. [PDF]

PLoS One
Portocarrero-Bonifaz A, Syed S, Kassel M, McKenzie GW, Shah VM, Forry BM, Gaskins JT, Sowards KT, Avula TB, Masters A, Schneider JG, Silva SR.   +11 more
europepmc   +1 more source

Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer. [PDF]

Clin Transl Radiat Oncol
Haack L, Krug D, Domschikowski J, Wittenstein O, Rodler S, Nuhn P, van der Horst C, Schmalz C, Schulz C, Blanck O, Siebert FA, Fabian A.   +11 more
europepmc   +1 more source

Preliminary Characterization of an Active CMOS Pad Detector for Tracking and Dosimetry in HDR Brachytherapy. [PDF]

Sensors (Basel)
Bui TNH, Large M, Poder J, Bucci J, Bianco E, Giampaolo RA, Rivetti A, Da Rocha Rolo M, Pastuovic Z, Corradino T, Pancheri L, Petasecca M.   +11 more
europepmc   +1 more source

Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism. [PDF]

J Appl Clin Med Phys
Radcliffe BA, Kim Y, Raffi J, Ayala-Peacock DN, Stephens SJ, Chino J, Meltsner S, Craciunescu O.   +7 more
europepmc   +1 more source

HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases - A dosimetric comparison study of three radioablative techniques. [PDF]

Clin Transl Radiat Oncol
Bilski M, Korab K, Stąpór-Fudzińska M, Ponikowska J, Brzozowska A, Sroka Ł, Wojtyna E, Sroka S, Szlag M, Cisek P, Napieralska A.   +10 more
europepmc   +1 more source